Metabotropic glutamate receptors: potential therapeutic applications of recently disclosed new chemical entities

Bibliography

• PIN JP, DUVOISIN R: The metabotropic glutamate receptors: Structure and functions. Neuropharmacology (1995) 34(1):1–26.
   PubMed Web of Science ®Google Scholar
• •One of the first comprehensive reviews on the mGlu family.
   Google Scholar
• KNOEPFEL T, KUHN R, ALLGEIER H: Metabotropic glutamate receptors: novel targets for drug development. I Med. Chem. (1995) 38(9):1417–1426.
   PubMed Web of Science ®Google Scholar
• CONN PJ, PIN JP: Pharmacology and functions of metabotropic glutamate receptors. Ann. Rev. Pharmacol. Toxicol (1997) 37:205–237.
   PubMed Web of Science ®Google Scholar
• ••Interesting review on the potentialities ofthe mGlu field.
   Google Scholar
• O'HARA PJ, SHEPPARD PO, THOGERSEN H et al.: The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron (1993) 11(1):41–52.
   Google Scholar
• KUNISHIMA N, SHIMADA Y, TSUJI Y et al.: Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature (London) (2000) 407(6807):971–977.
   PubMed Web of Science ®Google Scholar
• BROWN EM, GAMBA G, RICCARDI D et al.: Cloning and characterization of an extracellular Ca2'-sensing receptor from bovine parathyroid. Nature (London) (1993) 366 (6455):575–580.
   PubMed Web of Science ®Google Scholar
• KAUPMANN K, HUGGEL K, HEID J et al.: Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors. Nature (London) (1997) 386(6622):239–246.
   PubMed Web of Science ®Google Scholar
• BARGMANN CI: Olfactory receptors, vomeronasal receptors, and the organization of olfactory information. Cell (Cambridge, Massachusetts) (1997) 90(4):585–587.
   PubMed Web of Science ®Google Scholar
• PARMENTIER ML, PREZEAU L, BOCKAERT J et al.: A model for the functioning of family 3 GPCRs. Trends Pharmacol Sci. (2002) 23(6):268–274.
   PubMed Web of Science ®Google Scholar
• PIN JP, ACHER F: The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Curl: Drug Targ. CNS Neurol Dis. (2002) 1(3):297–317.
   PubMed Web of Science ®Google Scholar
• CONN JP, PIN JP: Pharmacology and functions of the metabotropic glutamate receptors. Ann. Rev. Pharmacol. Toxicol (1997) 37:205–237.
   PubMed Web of Science ®Google Scholar
• MICHELI F, DI FABIO R, BORDI F al: 2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: further characterization of 3,5-dimethyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 441,2,2-trimethyl-propyl) ester and structure-activity relationships. Bioorg. Med. Chem. Lett. (2003) 13(13):2113–2118.
   PubMed Web of Science ®Google Scholar
• ROPPE J, SMITH ND, HUANG D al: discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity. J. Med. Chem. (2004) 47(19):4645–4648.
   PubMed Web of Science ®Google Scholar
• MOVSESVAN VA, STOICA BA, FADEN Al: mGluR5 activation reduces 13-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor. J. Neurochem. (2004) 89(6):1528–1536.
   PubMed Web of Science ®Google Scholar
• O'BRIEN J, LEMAIRE W, WITTMANN M et al: A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain. J. Pharmacol Exp. Ther. (2004) 309(2):568–577.
   PubMed Web of Science ®Google Scholar
• CHAKI S, YOSHIKAWA R, HIROTA S et al: MG50039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity. Neuropharmacology (2004) 46(4)457–467.
   Google Scholar
• NAKAZATO A, YASUHARA A, SAKAGAMI K et al: Synthesis, in vitro pharmacology, structure-activity relationships, and pharmacokinetics of 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent and selective group II metabotropic glutamate receptor antagonists. J. Med. Chem. (2004) 47(18):4570–4587.
   Google Scholar
• COLLADO I, PEDREGAL C, BUENO AB et al: (2S, l'S,2'R,3V0-2-(2'-Carboxy-3'-hydroxymethylcyclopropyklycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity. J. Med. Chem. (2004) 47(2):456–466.
   PubMed Web of Science ®Google Scholar
• COLLADO I, PEDREGAL C, MAZON A et al.: (25,1'5,2'S, 3'R) -2- (2'-Carboxy-3'-methylcyclopropy0glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties. J. Med. Chem. (2002) 45(17):3619–3629.
   PubMed Web of Science ®Google Scholar
• SWANSON CJ, PERRY KW, SCHOEPP DD: The mG1u2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex. Neurochem. (2004) 88(1):194–202.
   PubMed Web of Science ®Google Scholar
• TIZZANO JP, GRIFFEY KI, SCHOEPP DD: The anxiolytic action of mG1u2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam. Pharmacol Biochem. Behav. (2002) 73(2):367–374.
   PubMed Web of Science ®Google Scholar
• SCHOEPP DD, MAREK GJ: Preclinical pharmacology of mG1u2/3 receptor agonists: novel agents for schizophrenia? Curr. Drug Targ. CNS Neurol Dis. (2002) 1(2):215–225.
   PubMed Web of Science ®Google Scholar
• SIMMONS RIVI, WEBSTER AA, KALRA AB et al: Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats. Pharmacol. Biochem. Behav (2002) 73(2):419–427.
   PubMed Web of Science ®Google Scholar
• PINKERTON AB, VERNIER JM, SCHAFFHAUSER H et al.: Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor. J. Med. Chem. (2004) 47(18):4595–4599.
   PubMed Web of Science ®Google Scholar
• KNOFLACH F, MUTEL V, JOLIDON S et al: Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site. Proc. Natl. Acad. Sci. USA (2001) 98:13402–13407.
   PubMed Web of Science ®Google Scholar
• MATHIESEN JM, SVENDSEN N, BRAUNER-OSBOURNE H et al: Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP. Br. Pharmacol (2003)138:1026–1030.
   PubMed Web of Science ®Google Scholar
• MAJ M, BRUNO V, GASPARINI F et al: (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection. Neuropharmacology (2003) 45(7):895–906.
   PubMed Web of Science ®Google Scholar